[1]
“In-Silico Analysis of Secondary Metabolites that Inhibit Aldose Reductase Targeting Diabetic Retinopathy”, J. Inst. Sci. Tech., vol. 30, no. 1, pp. 197–209, Jun. 2025, doi: 10.3126/jist.v30i1.76562.